Product Safety Recalls

Product Recall Tracker

IBUPROFEN Recall D-1055-2022

Description: Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61

IBUPROFEN Recall D-1055-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1055-2022
Event ID89646
BrandIBUPROFEN
Generic NameIBUPROFEN
ManufacturerIBUPROFEN
Active SubstanceIBUPROFEN
Drug RouteORAL
DistributionUSA nationwide.
Quantity1 carton/100 blisters per carton
Recall ReasoncGMP deviations: Temperature abuse
Drug ClassificationClass II
Drug Code Info20220615
Product NDC0904-5853 0904-5854 0904-5855
Product NUIN0000000160 M0001335 N0000175722
Pharma Class (EPC)Nonsteroidal Anti-inflammatory Drug [EPC]
Pharma Class (CS)Anti-Inflammatory Agents, Non-Steroidal [CS]
Recall Initiation Date20220413
Report Date20220615
Classification Date20220609
Address9954 Maryland DriveDeep Run Iii Ste. 4000
Richmond, VA 23233
United States
Recalling FirmMckesson Medical-Surgical Inc. Corporate Office
Initial Notification Letter
Unique Ingredient IdentifierWK2XYI10QM
Drug Application NumberANDA075682
Structured Product Labeling (SPL ID)84f91e64-4b87-4289-b004-150f5b173290
Structured Product Labeling (SPL Set ID)ba86e936-ef72-43e5-aebf-f2c788fe2266
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.